These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8158415)

  • 1. Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model.
    Fabris B; Fischetti F; Carretta R; Narducci P; Piccinini C; Calci M; Biagi A; Candido R; Bardelli M; Campanacci L
    J Hypertens Suppl; 1993 Dec; 11(5):S344-5. PubMed ID: 8158415
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor inhibitor PKI-166 governs cardiovascular protection without beneficial effects on the kidney in hypertensive 5/6 nephrectomized rats.
    Ulu N; Mulder GM; Vavrinec P; Landheer SW; Duman-Dalkilic B; Gurdal H; Goris M; Duin M; van Dokkum RP; Buikema H; van Goor H; Henning RH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):393-403. PubMed ID: 23528611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
    Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
    Siddiq T; Patel VB; Sherwood R; Richardson PJ; Preedy VR
    Exp Mol Pathol; 2001 Feb; 70(1):19-30. PubMed ID: 11170787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
    Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
    Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
    J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M; White R; Tan J; Huang BS; Leenen FH
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats.
    Vettoretti S; Ochodnicky P; Buikema H; Henning RH; Kluppel CA; de Zeeuw D; van Dokkum RP
    J Hypertens; 2006 Nov; 24(11):2215-23. PubMed ID: 17053543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
    Azzadin A; Małyszko J; Małyszko JS; Tankiewicz A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 2002; 54(5):469-73. PubMed ID: 12593533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.
    Larivière R; Moreau C; Rodrigue ME; Lebel M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of soy protein hydrolysate on blood pressure and angiotensin-converting enzyme activity in rats with chronic renal failure.
    Yang HY; Chen JR; Chang LS
    Hypertens Res; 2008 May; 31(5):957-63. PubMed ID: 18712051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model.
    Benigni A; Zoja C; Noris M; Corna D; Benedetti G; Bruzzi I; Todeschini M; Remuzzi G
    Am J Kidney Dis; 1999 Apr; 33(4):746-53. PubMed ID: 10196019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of systemic blood pressure to myocardial remodeling in uremic rats.
    Fabris B; Carretta R; Fischetti F; Candido R; Calci M; Castellano M; Bardelli M; Campanacci L
    Hypertension; 1995 Aug; 26(2):321-6. PubMed ID: 7635542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model.
    Terzi F; Beaufils H; Laouari D; Burtin M; Kleinknecht C
    Kidney Int; 1992 Aug; 42(2):354-63. PubMed ID: 1405318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.